Key result
Stagnant design and lack of transcatheter options drive a progressive decline in mechanical heart valve use.
Why the study?
The fundamental design of contemporary mechanical heart valves has remained largely unchanged for over half a century, with no established percutaneous treatment options for prosthetic valve dysfunction, limiting clinical use of MHVs.
Answers are grounded in this paper and cite their sources.
Highlights the stagnation in mechanical heart valve design and the lack of established percutaneous treatment options for their dysfunction.
Over the past 2 decades, structural heart interventions have undergone rapid and sustained technological advancement. In contrast, the fundamental design of contemporary mechanical heart valves (MHVs) has remained largely unchanged since their introduction more than half a century ago. This stagnation has been reinforced by the lack of established percutaneous treatment options for prosthetic valve dysfunction, including thrombosis, pannus overgrowth, and structural failure, contributing to a progressive decline in the clinical use of MHVs.
No takes yet. Share an insight, caveat, or question.
Jankowska et al. (2026) studied Prosthetic valve dysfunction. Valve-in-valve interventions in mechanical heart valves was evaluated. The fundamental design of mechanical heart valves has remained unchanged, with a lack of established percutaneous treatment options contributing to a progressive decline in their clinical use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: